Preliminary results of ibruntinib in combination with FCR chemotherapy for CLL
Key considerations for mutation detection in CLL
Diagnosis and Initial Treatment of CLL
Peter Hillmen et al.
Common side-effects of BTK inhibitors (ibrutinib and acalabrutinib) in the treatment of CLL
Trial results of idelalisib with bendamustine and rituximab in CLL